Vyome Holdings (HIND) Interest Coverage Ratio (2024 - 2026)
Vyome Holdings (HIND) posted Interest Coverage Ratio of 259.42 for Q2 2026, up 34.68% on a QoQ basis from 397.17 in Q1 2026, and down 4392.28% year-over-year from 6.04 in Q2 2025.
Powered by 
Analysis
Vyome Holdings (HIND) Interest Coverage Ratio (2024 - 2026) Analysis & Trends
Vyome Holdings has reported Interest Coverage Ratio for 3 years, with the latest figure at 259.42 in Q2 2026.
- On a quarterly basis, Interest Coverage Ratio fell 4392.28% year-over-year to 259.42 in Q2 2026; TTM through Jun 2026 was 285.77, a 5550.12% decrease from a year earlier, with the FY2025 full-year figure at 71.28, down 1359.15% from the prior year.
- Interest Coverage Ratio was 259.42 for Q2 2026 at Vyome Holdings, up from 397.17 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 3.62 in Q1 2025, with the low at 397.17 in Q1 2026.
- Average Interest Coverage Ratio over 3 years is 143.52, with a median of 71.21 recorded in 2024.
- The sharpest annual moves came in 2025 and 2026: Interest Coverage Ratio slumped 2709.18% in 2025, then slumped 10867.91% in 2026.
- Over 3 years, Interest Coverage Ratio stood at 4.85 in 2024, then sank by 2709.18% to 136.27 in 2025, then plunged by 90.37% to 259.42 in 2026.
- The last three Interest Coverage Ratio figures came in at 259.42 (Q2 2026), 397.17 (Q1 2026), and 136.27 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | Vyome Holdings | 14.46 Mn | 6.57 Mn | 11,658.00 | -259.42 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -259.42 |
| Mar 31, 2026 | -397.17 |
| Dec 31, 2025 | -136.27 |
| Sep 30, 2025 | -334.88 |
| Jun 30, 2025 | -5.77 |
| Mar 31, 2025 | -3.62 |
| Dec 31, 2024 | -4.85 |
| Sep 30, 2024 | -6.14 |